Clinical Trial Detail

NCT ID NCT02985658
Title Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer
Recruitment Available
Gender female
Phase Phase I
Variant Requirements Yes
Sponsors University of Washington
Indications

triple-receptor negative breast cancer

breast cancer

Therapies

Cisplatin

Veliparib

Vinorelbine

Age Groups: senior adult

Additional content available in CKB BOOST